Tapewire

Nasdaq · USD

RGEN

REPLIGEN CORP

Export transactions ↓
Tapewire entity
486
SEC CIK
0000730272
Parsed reports
388

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202601
Jul 202601
Aug 202601
Sep 202604
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 10, 2025 Filed Sep 11, 2025 18:55 UTC
Hunt AnthonyDirector
SaleCommon Stock 96 $116.34 $11,168.64
Disclosure

SEC source: 0001193125-25-201224 · ownership.xml · nonDerivative · entry 2

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,758

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

Read SEC document
September 10, 2025 Filed Sep 11, 2025 18:55 UTC
Hunt AnthonyDirector
Exercise / conversionCommon Stock 20,000 $33.87 $677,400.00
Disclosure

SEC source: 0001193125-25-201224 · ownership.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,854

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 14:55 UTC
Loeillot OlivierDirector · Chief Executive Officer
Tax withholdingCommon Stock 2,506 $116.18 $291,147.08
Disclosure

SEC source: 0001193125-25-195655 · ownership.xml · nonDerivative · entry 1

Loeillot Olivier · CIK 0001995525 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,187

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 16:47 UTC
Hughes ViolettaCHIEF ACCOUNTING OFFICER
GrantStock Option (Right to Buy) · Derivative 3,914 $0.00 Strike: $120.69 $0.00
Disclosure

SEC source: 0000950170-25-112985 · ownership.xml · derivative · entry 2

Hughes Violetta · CIK 0001991429 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,914

Underlying: Common Stock · 3,914 shares

Expires 2035-09-02

F2 · derivative.exercise_date: The shares vest in equal annual instalments over a five-year period with each such vesting date occurring on the anniversary of the grant date.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 16:47 UTC
Hughes ViolettaCHIEF ACCOUNTING OFFICER
GrantCommon Stock 4,142 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-112985 · ownership.xml · nonDerivative · entry 1

Hughes Violetta · CIK 0001991429 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,142

F1 · shares: Ms. Hughes was awarded 4,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a five-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 16:47 UTC PurchaseCommon Stock 1,800 $112.13 $201,830.40
Disclosure

SEC source: 0000950170-25-107084 · ownership.xml · nonDerivative · entry 1

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Martin D. Madaus 2011 Revocable Trust

Disclosed balance after: 1,800

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $111.72 to $112.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
May 15, 2025 Filed May 16, 2025 19:02 UTC
Hunt AnthonyDirector
SaleCommon Stock 7 $127.00 $889.00
Disclosure

SEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 5

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,854

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

Read SEC document
May 15, 2025 Filed May 16, 2025 19:02 UTC
Hunt AnthonyDirector
SaleCommon Stock 268 $125.20 $33,553.60
Disclosure

SEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 4

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,861

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F5 · price: $125.20 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.06 to $126.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 15, 2025 Filed May 16, 2025 19:02 UTC
Hunt AnthonyDirector
SaleCommon Stock 6,533 $124.34 $812,313.22
Disclosure

SEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 3

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,129

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F4 · price: $124.34 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.05 to $125.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 15, 2025 Filed May 16, 2025 19:02 UTC
Hunt AnthonyDirector
SaleCommon Stock 17,596 $123.57 $2,174,337.72
Disclosure

SEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 2

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,662

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F3 · price: $123.57 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.04 to $124.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 15, 2025 Filed May 16, 2025 19:02 UTC
Hunt AnthonyDirector
SaleCommon Stock 2,043 $122.66 $250,594.38
Disclosure

SEC source: 0000950170-25-073387 · ownership.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,258

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F2 · price: $122.66 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.03 to $123.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 15, 2025 Filed May 20, 2025 00:26 UTC GrantStock Option (Right to Buy) · Derivative 1,800 $0.00 Strike: $123.26 $0.00
Disclosure

SEC source: 0000950170-25-074761 · ownership.xml · derivative · entry 2

Konstantinov Konstantin · CIK 0001774649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2035-05-15

F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 15, 2025 Filed May 20, 2025 00:26 UTC GrantCommon Stock 973 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-074761 · ownership.xml · nonDerivative · entry 1

Konstantinov Konstantin · CIK 0001774649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,894

F1 · shares: Mr. Konstantinov was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 15, 2025 Filed May 20, 2025 00:19 UTC
MUIR GLENN PDirector
GrantStock Option (Right to Buy) · Derivative 1,800 $0.00 Strike: $123.26 $0.00
Disclosure

SEC source: 0000950170-25-074752 · ownership.xml · derivative · entry 2

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2035-05-15

F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 15, 2025 Filed May 20, 2025 00:19 UTC
MUIR GLENN PDirector
GrantCommon Stock 973 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-074752 · ownership.xml · nonDerivative · entry 1

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,256

F1 · shares: Mr. Muir was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 15, 2025 Filed May 20, 2025 00:16 UTC GrantStock Option (Right to Buy) · Derivative 1,800 $0.00 Strike: $123.26 $0.00
Disclosure

SEC source: 0000950170-25-074747 · ownership.xml · derivative · entry 2

EGLINTON MANNER CARRIE · CIK 0001696776 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2035-05-15

F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 15, 2025 Filed May 20, 2025 00:16 UTC GrantCommon Stock 973 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-074747 · ownership.xml · nonDerivative · entry 1

EGLINTON MANNER CARRIE · CIK 0001696776 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,466

F1 · shares: Ms. Manner was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 15, 2025 Filed May 19, 2025 19:27 UTC GrantStock Option (Right to Buy) · Derivative 1,800 $0.00 Strike: $123.26 $0.00
Disclosure

SEC source: 0000950170-25-074251 · ownership.xml · derivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2035-05-15

F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 15, 2025 Filed May 19, 2025 19:27 UTC GrantCommon Stock 973 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-074251 · ownership.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,096

F1 · shares: Ms. Dawes was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 15, 2025 Filed May 19, 2025 19:05 UTC GrantStock Option (Right to Buy) · Derivative 1,800 $0.00 Strike: $123.26 $0.00
Disclosure

SEC source: 0000950170-25-074224 · ownership.xml · derivative · entry 3

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2035-05-15

F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 15, 2025 Filed May 19, 2025 19:05 UTC GrantCommon Stock 973 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-074224 · ownership.xml · nonDerivative · entry 1

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,586

F1 · shares: Mr. Madaus was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 15, 2025 Filed May 19, 2025 18:59 UTC
Pax MargaretDirector
GrantStock Option (Right to Buy) · Derivative 1,800 $0.00 Strike: $123.26 $0.00
Disclosure

SEC source: 0000950170-25-074216 · ownership.xml · derivative · entry 2

Pax Margaret · CIK 0001999772 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2035-05-15

F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 15, 2025 Filed May 19, 2025 18:59 UTC
Pax MargaretDirector
GrantCommon Stock 973 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-074216 · ownership.xml · nonDerivative · entry 1

Pax Margaret · CIK 0001999772 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,016

F1 · shares: Ms. Pax was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 15, 2025 Filed May 19, 2025 18:38 UTC
Mhatre RohinDirector
GrantStock Option (Right to Buy) · Derivative 1,800 $0.00 Strike: $123.26 $0.00
Disclosure

SEC source: 0000950170-25-074196 · ownership.xml · derivative · entry 2

Mhatre Rohin · CIK 0001798735 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2035-05-15

F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 15, 2025 Filed May 19, 2025 18:38 UTC
Mhatre RohinDirector
GrantCommon Stock 973 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-074196 · ownership.xml · nonDerivative · entry 1

Mhatre Rohin · CIK 0001798735 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,019

F1 · shares: Mr. Mhatre was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 15, 2025 Filed May 21, 2025 19:00 UTC GrantStock Option (Right to Buy) · Derivative 1,800 $0.00 Strike: $123.26 $0.00
Disclosure

SEC source: 0000950170-25-075705 · ownership.xml · derivative · entry 2

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

Underlying: Common Stock · 1,800 shares

Expires 2035-05-15

F2 · derivative.exercise_date: Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 15, 2025 Filed May 21, 2025 19:00 UTC GrantCommon Stock 973 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-075705 · ownership.xml · nonDerivative · entry 1

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,441

F1 · shares: Mr. Barthelemy was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
April 01, 2025 Filed Apr 2, 2025 14:33 UTC
Bylund JamesChief Operating Officer
Tax withholdingCommon Stock 454 $128.50 $58,339.00
Disclosure

SEC source: 0000950170-25-048942 · ownership.xml · nonDerivative · entry 1

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,711

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 19:58 UTC
Pax MargaretDirector
PurchaseCommon Stock 250 $150.69 $37,672.50
Disclosure

SEC source: 0000950170-25-041119 · ownership.xml · nonDerivative · entry 1

Pax Margaret · CIK 0001999772 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,043

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 21,756 $0.00 Strike: $59.52 $0.00
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · derivative · entry 10

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,756 shares

Expires 2029-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $33.87 $0.00
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · derivative · entry 9

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 202,344

Underlying: Common Stock · 5,000 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: 207,344 of the shares underlying this option have vested. The remaining shares vest as follows: 28,777 shares on March 1, 2026, and 28,778 shares on March 1, 2027.

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
SaleCommon Stock 2,283 $153.70 $350,897.10
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 8

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136,301

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F6 · price: $153.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.55 to $153.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
SaleCommon Stock 15,619 $152.82 $2,386,895.58
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 7

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,584

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F5 · price: $152.82 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.39 to $153.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
SaleCommon Stock 6,176 $151.96 $938,504.96
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 6

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,203

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F4 · price: $151.96 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.43 to $152.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
SaleCommon Stock 2,518 $151.09 $380,444.62
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 5

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,379

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F3 · price: $151.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.42 to $151.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
SaleCommon Stock 100 $150.38 $15,038.00
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 4

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,897

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
SaleCommon Stock 60 $148.05 $8,883.00
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 3

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,997

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.

F2 · price: $148.05 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.01 to $148.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
Exercise / conversionCommon Stock 21,756 $59.52 $1,294,917.12
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 2

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:21 UTC
Hunt AnthonyDirector
Exercise / conversionCommon Stock 5,000 $33.87 $169,350.00
Disclosure

SEC source: 0000950170-25-042026 · ownership.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,301

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2025 Filed Mar 20, 2025 17:51 UTC
Bylund JamesChief Operating Officer
Tax withholdingCommon Stock 175 $142.44 $24,927.00
Disclosure

SEC source: 0000950170-25-042471 · ownership.xml · nonDerivative · entry 2

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,165

F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of the performance stock units.

Read SEC document
March 13, 2025 Filed Mar 20, 2025 17:51 UTC
Bylund JamesChief Operating Officer
GrantCommon Stock 381 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-042471 · ownership.xml · nonDerivative · entry 1

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,340

F1 · shares: Represents 63 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on May 16, 2023, and 318 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on December 12, 2023. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 18:42 UTC GrantStock Option (Right to Buy) · Derivative 6,056 $0.00 Strike: $155.38 $0.00
Disclosure

SEC source: 0000950170-25-031593 · ownership.xml · derivative · entry 2

Garland Jason K · CIK 0001754555 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,056

Underlying: Common Stock · 6,056 shares

Expires 2035-03-03

F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 18:42 UTC GrantCommon Stock 6,435 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-031593 · ownership.xml · nonDerivative · entry 1

Garland Jason K · CIK 0001754555 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,795

F1 · shares: Mr. Garland was awarded 6,435 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 18:41 UTC
KURIYEL RALFSenior VP, R&D
GrantStock Option (Right to Buy) · Derivative 4,542 $0.00 Strike: $155.38 $0.00
Disclosure

SEC source: 0000950170-25-031591 · ownership.xml · derivative · entry 3

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,542

Underlying: Common Stock · 4,542 shares

Expires 2035-03-03

F3 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 18:41 UTC
KURIYEL RALFSenior VP, R&D
Tax withholdingCommon Stock 386 $155.38 $59,976.68
Disclosure

SEC source: 0000950170-25-031591 · ownership.xml · nonDerivative · entry 2

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,062

F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 18:41 UTC
KURIYEL RALFSenior VP, R&D
GrantCommon Stock 4,826 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-031591 · ownership.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,448

F1 · shares: Mr. Kuriyel was awarded 4,826 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 18:30 UTC
Hunt AnthonyDirector
Tax withholdingCommon Stock 10,142 $155.38 $1,575,863.96
Disclosure

SEC source: 0000950170-25-031572 · ownership.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,301

F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 18:29 UTC
Bylund JamesChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 6,056 $0.00 Strike: $155.38 $0.00
Disclosure

SEC source: 0000950170-25-031569 · ownership.xml · derivative · entry 3

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,056

Underlying: Common Stock · 6,056 shares

Expires 2035-03-03

F3 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 18:29 UTC
Bylund JamesChief Operating Officer
Tax withholdingCommon Stock 1,239 $155.38 $192,515.82
Disclosure

SEC source: 0000950170-25-031569 · ownership.xml · nonDerivative · entry 2

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,959

F2 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 18:29 UTC
Bylund JamesChief Operating Officer
GrantCommon Stock 6,435 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-031569 · ownership.xml · nonDerivative · entry 1

Bylund James · CIK 0001849642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,198

F1 · shares: Mr. Bylund was awarded 6,435 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.